Regulate or ban: Experts debate future of direct-to-consumer drug advertising

In a position statement published earlier this year, the American College of Clinical Pharmacy called for the total withdrawal of direct-to-consumer advertising for medications in the United States. The paper, published in April in the Journal of the American College of Clinical Pharmacy, stated that although such advertisements may increase disease awareness and encourage patient engagement,